Clinical trial · no report yet · Phase 2/Phase 3
NCT02364557
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
- NCT02364557 ↗
- Completed
- NRG Oncology
- 35 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 20 | |
| YouTube | 9 | |
| Podcasts | 6 |
The trial
ClinicalTrials.gov- Official title
- A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
- Phase
- Phase 2/Phase 3
- Status
- Completed
- Conditions
- Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Liver; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Lymph Nodes; Metastatic Malignant Neoplasm in the Spine; Prognostic Stage IV Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8
- Interventions
- Stereotactic Body Radiotherapy; Surgery
- Arms
- Standard of Care (SOC) · No intervention
- Standard of Care + Ablation · Experimental
- Enrollment
- 129
- Primary outcomes
- Progression-free Survival (Phase II)
- Overall Survival (Phase III)
- Sponsor
- NRG Oncology with National Cancer Institute (NCI)
- Start
- Dec 24, 2014
- Primary completion
- Dec 20, 2021
- Results posted
- Yes
- Registry record
- NCT02364557 · updated Jul 10, 2026
Publications
linked from the registry- Petrelli F, Ghidini A, Ghidini M, Bukovec R, Trevisan F, Turati L, Indini A, Seghezzi S, Lonati V, Moleri G, Tomasello G, Zaniboni A. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Res. 2021 May 27;10:423. doi: 10.12688/f1000research.52546.4. eCollection 2021. PubMed 35602670